Literature DB >> 14086772

THE METABOLISM OF GAMMA GLOBULINS IN MYELOMA AND ALLIED CONDITIONS.

C A ALPER, T FREEMAN, J WALDENSTROEM.   

Abstract

Keywords:  BLOOD PROTEIN DISORDERS; BLOOD PROTEIN ELECTROPHORESIS; GAMMA GLOBULIN; GERIATRICS; IODINE ISOTOPES, DIAGNOSTIC; MACROGLOBULINEMIA; MULTIPLE MYELOMA; PROTEIN METABOLISM DISORDERS

Mesh：

Substances：

Year:  1963        PMID： 14086772      PMCID： PMC289472          DOI： 10.1172/JCI104870

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  32 in total

1.  The turnover and distribution of I-131-labeled myeloma and macroglobulin proteins.

Authors:  T G GABUZDA
Journal:  J Lab Clin Med       Date:  1962-01

2.  A practical method for plasma albumin turnover studies.

Authors:  J D PEARSON; N VEALL; H VETTER
Journal:  Strahlentherapie       Date:  1958

3.  Hypogammaglobulinaemia in myeloma.

Authors:  R D EASTHAM; W B YEOMAN
Journal:  Acta Med Scand       Date:  1960-03-30

4.  Protein chromatography on ion exchange cellulose.

Authors:  H A SOBER; E A PETERSON
Journal:  Fed Proc       Date:  1958-12

5.  A new concept of the metabolism of the pathological proteins in myelomatosis.

Authors:  A H NEUFELD
Journal:  Can J Biochem Physiol       Date:  1957-11

6.  The metabolism of 3:3':5'-triiodothyronine in man.

Authors:  J T DUNN; J B STANBURY
Journal:  J Clin Endocrinol Metab       Date:  1958-07       Impact factor: 5.958

7.  The isolation of gamma globulin from blood-serum by rivanol.

Authors:  J HOREJSI; R SMETANA
Journal:  Acta Med Scand       Date:  1956-06-30

8.  The distribution of I131 labeled human serum albumin introduced into ascitic fluid: analysis of the kinetics of a three compartment catenary transfer system in man and speculations on possible sites of degradation.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1954-03       Impact factor: 14.808

9.  The kinetics of the distribution and breakdown of 1131-albumin in the rabbit. Observations on several mathematical descriptions.

Authors:  E B REEVE; J E ROBERTS
Journal:  J Gen Physiol       Date:  1959-11       Impact factor: 4.086

10.  The nature and rates of excretion of radioactive breakdown products of I131-albumin in the rabbit.

Authors:  F ZIZZA; T J CAMPBELL; E B REEVE
Journal:  J Gen Physiol       Date:  1959-11       Impact factor: 4.086
View more
  9 in total

1.  Metabolism of autologous and homologous IgG in rheumatoid arthritis.

Authors:  M A Catalano; E H Krick; D H De Heer; R M Nakamura; A N Theofilopoulos; J H Vaughan
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

2.  Metabolism of radio-iodinated IgG in patients with abnormal serum IgG levels. II. Hypogamma-globulinaemia.

Authors:  J V Wells; H H Fudenberg
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

3.  Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema.

Authors:  M Quastel; R Harrison; M Cicardi; C A Alper; F S Rosen
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

4.  Metabolism of radio-iodinated IgG in patients with abnormal IgG levels. I. Hypergamma-globulinaemia.

Authors:  J V Wells; H H Fudenberg
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

5.  Metabolism of properdin in normal subjects and patients with renal disease.

Authors:  J B Ziegler; F S Rosen; C A Alper; W Grupe; I H Lepow
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

6.  PWM-induced generation of immunoglobulin-secreting cells in patients with multiple myeloma.

Authors:  G Sieber; B Enders; H Rühl
Journal:  Klin Wochenschr       Date:  1981-10-01

7.  Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma.

Authors:  S E Salmon; B A Smith
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

8.  Metabolism of IgG in type II mixed essential cryoglobulinaemia--autologous cryoprecipitated and normal homologous IgG are incorporated into complexes and metabolized in vivo at similar rates.

Authors:  J A Schifferli; N Amos; C D Pusey; J G Sissons; D K Peters
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

9.  Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.

Authors:  C A Alper; F S Rosen
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.